Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
Go back to Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
September 23, 2015 6:46 AM EDT
Intra-Cellular Therapies (NASDAQ: ITCI) announced the pricing of its previously announced underwritten public offering of 6,900,000 shares of its common stock at a public offering price of $43.50 per share. All of the shares in the offering will be sold by Intra-Cellular Therapies. Net proceeds to... More
September 21, 2015 4:12 PM EDT
Intra-Cellular Therapies (NASDAQ: ITCI) announced that it has commenced an underwritten public offering of $300 million of shares of its common stock. In connection with the offering, Intra-Cellular Therapies intends to grant the underwriters a 30-day option to purchase up to an additional 15%... More
September 21, 2015 4:12 PM EDT
Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company, today announced that it has commenced an underwritten public offering of $300 million of shares of its common stock. In connection with the offering, Intra-Cellular Therapies intends to grant the underwriters a 30-day option to... More
